Accessibility Menu
Solesence logo

Solesence(NASDAQ) NANX

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-88%
5 Year-61%
1 Year-79%
1 Month+13%
N/A
Solesence last closing stock price
MetricPriceDate
Last closeUSD 0.932026-07-27
Solesence stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+27.32%USD 0.732026-07-20
1 month+12.69%USD 0.832026-06-26
3 month-32.14%USD 1.372026-04-28
Year to date-41.71%USD 1.602025-12-31
1 year-78.58%USD 4.342025-07-25
3 year-32.63%USD 1.382023-07-28
5 year-60.69%USD 2.372021-07-28
Since inception-88.25%USD 8.001997-11-26

Solesence Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$60.40M

Net Income (TTM)

$944.00K

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Mar 26, 2025

NANX News

Nanophase Paints the Town

Jack UldrichApr 18, 2007

Nanophase Picks Up the Pace

Jack UldrichApr 12, 2007

Nanophase on Solid Ground

Jack UldrichJan 23, 2007

HP Spurns Intel

Motley Fool StaffSep 27, 2004

What's Lifting Netflix?

Motley Fool StaffAug 28, 2003

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Solesence

Solesence makes mineral-based skincare and makeup for beauty brands. Its products help protect skin from sun and pollution. The company supplies ingredients and finished goods to global and indie brands.

What’s in the Bottle? (Products and Services)

  • Consumer Products (88%): Skincare, sun care, and makeup made for other brands to sell under their own names.
  • Personal Care Ingredients (10%): Zinc oxide and titanium dioxide powders for sunscreens and skin health, sold to large companies.
  • Advanced Materials (1.4%): Nanoparticle materials for uses like lab tests and food packaging, a small legacy segment.

Growth Spurts and Global Moves

  • Expanded consumer product line to over 950 items by 2025.
  • Formed exclusive supply partnership with BASF for zinc oxide ingredients.
  • Consolidated manufacturing into two Chicago-area sites in 2025 for efficiency.
  • Increased international sales, with UK revenue rising from $0.6 million in 2024 to $3.3 million in 2025.
  • Invested $4.1 million in research and development in 2025 to support new product innovation.

Why Solesence Stands Out (Without the Hype)

Solesence controls the process from raw materials to finished products, allowing quick innovation. Its patented technology helps brands offer sun and pollution protection in their products. The company meets strict U.S. and international safety standards for all its offerings.

Five Things You Need to Know

  • Total revenue was $62.1 million in 2025, up 18.6% from 2024.
  • Consumer Products made up 88% of revenue in 2025, up from 85% in 2024.
  • Gross profit was $16.1 million in 2025, flat from 2024.
  • Net income was $1.8 million in 2025, down from $4.2 million in 2024.
  • International sales reached $5.2 million in 2025, 8.3% of total revenue.

Bottom Line

Solesence has shifted from materials to branded beauty solutions for other companies. Its focus on innovation and partnerships has driven growth, but customer concentration and cost pressures remain key factors.

AI Generated • Apr 16, 2026

Industry

Chemicals

Sector

Materials

Employees

115

CEO

Kevin Cureton, MBA

Website

www.solesence.com

Headquarters

Romeoville, IL 60446, US

NANX Financials

Key Financial Metrics (TTM)

Gross Margin

26.49%

Operating Margin

1.34%

Net Income Margin

1.56%

Return on Equity

5.39%

Return on Capital

4.34%

Return on Assets

1.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$16.02M

Operating Income

$812.00K

EBITDA

$2.54M

Operating Cash Flow

$171.00K

Capital Expenditure

$0.00

Free Cash Flow

$171.00K

Cash & ST Invst.

$573.00K

Total Debt

$18.24M

Solesence Performance Analysis

Solesence annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 37,317,00026.6%
20232023-12-31USD 37,297,000-0.1%
20242024-12-31USD 52,347,00040.4%
20252025-12-31USD 62,064,00018.6%
Solesence sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3039.2%
Q32025-09-30-28.3%
Q42025-12-31-14.5%
Q12026-03-313.8%
Solesence annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.05N/A
20232023-12-31USD -0.0965.9%
20242024-12-31USD 0.07N/A
20252025-12-31USD 0.02-62.1%
Solesence sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-303536.4%
Q32025-09-30-150.0%
Q42025-12-31105.5%
Q12026-03-31-1009.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$12.96M

-11.4%

Gross Profit

$3.34M

-1.3%

Gross Margin

25.75%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

79

N/A

Net Income

-$766.00K

-1057.5%

EBITDA

-$498.00K

-203.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$573.00K

-68.5%

Total Debt

$18.24M

-19.2%

Accounts Receivable

$7.25M

-20.2%

Inventory

$17.56M

-19.9%

Long Term Debt

$16.94M

-3.0%

Short Term Debt

$1.30M

-90.6%

Return on Assets

1.98%

N/A

Return on Invested Capital

2.31%

N/A

Free Cash Flow

$1.52M

+121.0%

Operating Cash Flow

$1.52M

+121.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HERCH.E.R.C. Products Inc.
$0.02+18950.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.67-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
AALAmerican Airlines Group
$14.95+0.03%

Questions About NANX

What is the current price of Solesence?

Solesence is trading at N/A per share.

What is the 52-week range for Solesence?

Over the past 52 weeks, Solesence has traded between N/A and N/A.

How much debt does Solesence have?

As of the most recent reporting period, Solesence reported total debt of $22.28M.

How much cash does Solesence have on hand?

Solesence reported $573.00K in cash and cash equivalents in its most recent financial results.

What is Solesence’s dividend yield?

Solesence does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services